Henry Schein Inc (HSIC) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
Total Assets Chart for Henry Schein Inc
Henry Schein Inc (HSIC) total assets for FY2025 were USD 11.2B, a 9.8% change from FY2024. Henry Schein Inc's total assets grew from USD 190.0M in 1994 to USD 11.2B in 2025 (5802.6% over 31 years). Total assets compound annual growth rate: 5-year CAGR of 7.6%, 10-year CAGR of 5.2%, 20-year CAGR of 7.0%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $9.67B
- Implied Share Price
- $84.88
- Enterprise Value
- $13.12B
- Revenue (TTM)
- $13.60B
- EBITDA
- $1.08B
- Profit Margin
- 2.96%
- Trailing P/E
- 24.75
- Forward P/E
- 14.39
- Price/Book (MRQ)
- 3.00
- Price/Sales (TTM)
- 0.70
- EV/EBITDA
- 12.99
- EV/Revenue
- 0.96
- Dividend Yield
- —
- Book Value
- $28.21
- Free Cash Flow (FY2025)
- $573.00M
- Free Cash Flow Yield
- 5.93%
Snapshot as of 2nd November 2026 — not point-in-time controlled, may lag the live market by a few days.